Growth Metrics

Calidi Biotherapeutics (CLDI) Current Leases (2022 - 2025)

Calidi Biotherapeutics' quarterly Current Leases came in at $111000.0 in Q4 2025, up 68.18% year-on-year from $66000.0 in Q4 2024, and down 0.89% quarter-over-quarter from $112000.0 in Q3 2025.

Calidi Biotherapeutics has reported Current Leases for 4 years, with the latest figure at $111000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Current Leases rose 68.18% year-over-year to $111000.0; the trailing twelve-month figure through Dec 2025 stood at $111000.0 (up 68.18% YoY), and the FY2025 full-year result was $111000.0, up 68.18% from the prior year.
  • Current Leases for Q4 2025 stood at $111000.0, down from $112000.0 in the prior quarter.
  • The five-year high for Current Leases was $1.3 million in Q2 2025, with the low at $47000.0 in Q3 2022.
  • Average Current Leases over 4 years is $225857.1, with a median of $71500.0 recorded in 2022.
  • Year-over-year, Current Leases tumbled 92.89% in 2024 and soared 1817.65% in 2025.
  • Tracing CLDI's Current Leases over 4 years: stood at $72000.0 in 2022, then gained by 12.5% to $81000.0 in 2023, then declined by 18.52% to $66000.0 in 2024, then surged by 68.18% to $111000.0 in 2025.
  • The last three Current Leases figures came in at $111000.0 (Q4 2025), $112000.0 (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 83,991.00
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 720.00 Mn
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 45.66 Mn
10 Calidi Biotherapeutics - - - 111,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 111,000.00
Sep 30, 2025 112,000.00
Jun 30, 2025 1.30 Mn
Mar 31, 2025 69,000.00
Dec 31, 2024 66,000.00
Sep 30, 2024 69,000.00
Jun 30, 2024 68,000.00
Mar 31, 2024 74,000.00
Dec 31, 2023 81,000.00
Sep 30, 2023 62,000.00
Jun 30, 2023 956,000.00
Mar 31, 2023 71,000.00
Dec 31, 2022 72,000.00
Sep 30, 2022 47,000.00